Edgar Filing: CONMED CORP

Ownership Submission

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0104

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

Â Snyder Mark D

2. Date of Event Requiring Statement (Month/Day/Year)
02/25/2015

3. Issuer Name and Ticker or Trading Symbol
CONMED CORP [CNMD]

(Last)

(First)

(Middle)

C/O CONMED CORPORATION,Â 525 FRENCH ROAD

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	_____ 10% Owner
__X__ Officer (give title below)	_____ Other (specify below)
EVP Mfg. Operations & Supply

5. If Amendment, Date Original Filed(Month/Day/Year)

(Street)

UTICA,Â NYÂ 13502

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	8,104	D	Â

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Rsus (restricted Stock Units)	Â ⁽¹⁾	06/01/2020	Common Stock	800	$ 0	D	Â
Rsus (restricted Stock Units)	Â ⁽²⁾	06/01/2020	Common Stock	1,760	$ 0	D	Â
Rsus (restricted Stock Units)	Â ⁽¹⁾	06/01/2021	Common Stock	1,600	$ 0	D	Â
Rsus (restricted Stock Units)	Â ⁽¹⁾	06/01/2022	Common Stock	2,400	$ 0	D	Â
Rsus (restricted Stock Units)	Â ⁽¹⁾	06/01/2023	Common Stock	3,200	$ 0	D	Â
Rsus (restricted Stock Units)	Â ⁽¹⁾	06/01/2024	Common Stock	2,600	$ 0	D	Â
Sars (Stock Appreciation Rights)	Â ⁽³⁾	06/01/2020	Common Stock	6,000	$ 19.26	D	Â
Sars (Stock Appreciation Rights)	Â ⁽³⁾	06/01/2021	Common Stock	10,000	$ 27.63	D	Â
Sars (Stock Appreciation Rights)	Â ⁽³⁾	06/01/2022	Common Stock	10,000	$ 26.09	D	Â
Sars (Stock Appreciation Rights)	Â ⁽³⁾	06/01/2023	Common Stock	10,000	$ 32.93	D	Â
Sars (Stock Appreciation Rights)	Â ⁽³⁾	06/01/2024	Common Stock	6,500	$ 44.9	D	Â

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Snyder Mark D C/O CONMED CORPORATION 525 FRENCH ROAD UTICA,Â NYÂ 13502	Â	Â	Â EVP Mfg. Operations & Supply	Â

Signatures

/s/ Daniel S. Jonas for Mark D. Snyder by Power of Attorney		03/05/2015
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.
(2)	Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs vesting over a seven year period with 14% of the RSU's vesting in the first through the fifth year after the grant date and 15% vesting in the sixth and seventh year.
(3)	The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.